Correlation Between Qualigen Therapeutics and Societe Generale
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Societe Generale at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Societe Generale into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Societe Generale ADR, you can compare the effects of market volatilities on Qualigen Therapeutics and Societe Generale and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Societe Generale. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Societe Generale.
Diversification Opportunities for Qualigen Therapeutics and Societe Generale
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Qualigen and Societe is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Societe Generale ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Societe Generale ADR and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Societe Generale. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Societe Generale ADR has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Societe Generale go up and down completely randomly.
Pair Corralation between Qualigen Therapeutics and Societe Generale
Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Societe Generale. In addition to that, Qualigen Therapeutics is 4.62 times more volatile than Societe Generale ADR. It trades about -0.04 of its total potential returns per unit of risk. Societe Generale ADR is currently generating about 0.02 per unit of volatility. If you would invest 485.00 in Societe Generale ADR on August 31, 2024 and sell it today you would earn a total of 51.00 from holding Societe Generale ADR or generate 10.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Qualigen Therapeutics vs. Societe Generale ADR
Performance |
| Timeline |
| Qualigen Therapeutics |
| Societe Generale ADR |
Qualigen Therapeutics and Societe Generale Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Qualigen Therapeutics and Societe Generale
The main advantage of trading using opposite Qualigen Therapeutics and Societe Generale positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Societe Generale can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Societe Generale will offset losses from the drop in Societe Generale's long position.| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
| Societe Generale vs. BNP Paribas SA | Societe Generale vs. Credit Agricole SA | Societe Generale vs. Intesa Sanpaolo SpA | Societe Generale vs. Commerzbank AG PK |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |